Ann Clin Microbiol 2025;28(3):12. Clinical impact of the coronavirus disease 2019 pandemic on the quality of pulmonary tuberculosis management with national reimbursement data in Korea: a retrospective cohort study

Download table
Table 2. Comparison of mortality rates in patients with pulmonary tuberculosis before and during pandemic phase of COVID-19
GroupsTime periodBefore COVID-19 (%)
[Lower limit, Upper limit]		During COVID-19 (%)
[Lower limit, Upper limit]		Log-rank P
Total
(n = 75,024)		After 1 year12.30 [12.14–12.46]14.63 [14.43–14.83]< 0.0001
After 2 years16.14 [15.96–16.32]18.90 [18.67–19.13] 
Without alcohol dependence
(n = 71,767)		After 1 year12.19 [12.13–12.35]14.51 [14.31–14.71]< 0.0001
After 2 years15.88 [15.70–16.06]18.68 [18.45–18.91] 
With alcohol dependence
(n = 3,257)		After 1 year14.89 [14.06–15.72]17.31 [16.30–18.32]< 0.0001
After 2 years21.96 [21.00–22.92]23.50 [22.31–24.69] 
Without diabetes
(n = 38,041)		After 1 year7.74 [7.56–7.92]9.19 [8.96–9.42]< 0.0001
After 2 years10.18 [9.98–10.38]12.00 [11.73–12.27] 
With diabetes
(n = 36,983)		After 1 year16.41 [17.17–17.68]19.63 [19.32–19.94]< 0.0001
After 2 years22.81 [22.52–23.10]25.27 [24.92–25.62] 
Without malnutrition
(n = 71,991)		After 1 year11.72 [11.58–11.86]13.84 [13.67–14.01]< 0.0001
After 2 years15.35 [15.17–15.53]18.04 [17.81–18.27] 
With malnutrition
(n = 3,033)		After 1 year26.88 [25.79–27.97]29.96 [28.73–31.19]< 0.0001
After 2 years35.86 [34.56–37.17]38.00 [36.62–39.38] 
Without HIV infection
(n = 74,913)		After 1 year12.30 [12.14–12.46]14.63 [14.43–14.83]0.7871
After 2 years16.14 [15.96–16.32]18.89 [18.69–19.10] 
With HIV infection
(n = 111)		After 1 year13.84 [9.12–18.57]15.22 [9.92–20.52]0.3566
After 2 years18.46 [13.65–23.27]22.70 [16.34–29.06] 

Abbreviations: COVID-19, coronavirus disease 2019; HIV, human immunodeficiency virus.
Bold form: statistically significant Legend for figures